Mon, June 14, 2021
Sun, June 13, 2021
Fri, June 11, 2021
Thu, June 10, 2021
Wed, June 9, 2021
Tue, June 8, 2021
Mon, June 7, 2021
Fri, June 4, 2021
Thu, June 3, 2021
Wed, June 2, 2021
Tue, June 1, 2021

Silvan Tuerkcan Initiated (TSHA) at Buy and Held Target at $40 on, Jun 8th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-40-on-jun-8th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Silvan Tuerkcan of JMP Securities, Initiated "Taysha Gene Therapies, Inc." (TSHA) at Buy and Held Target at $40 on, Jun 8th, 2021.

Silvan has made no other calls on TSHA in the last 4 months.



There are 4 other peers that have a rating on TSHA. Out of the 4 peers that are also analyzing TSHA, 0 agree with Silvan's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Silvan


  • Kristen Kluska of "Cantor Fitzgerald" Initiated at Buy and Held Target at $44 on, Wednesday, May 19th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $43 on, Tuesday, April 13th, 2021
  • Gbola Amusa of "Chardan Capital" Maintained at Strong Buy with Increased Target to $68 on, Tuesday, April 13th, 2021
  • Raju Prasad of "William Blair" Initiated at Buy and Held Target at $46 on, Wednesday, February 24th, 2021

Publication Contributing Sources